Singapore markets closed

Medtronic plc (MDT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
85.92+0.28 (+0.33%)
At close: 04:00PM EDT
86.06 +0.14 (+0.16%)
Pre-market: 04:45AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 114.09B
Enterprise value 130.95B
Trailing P/E 27.28
Forward P/E 15.72
PEG ratio (5-yr expected) 1.63
Price/sales (ttm)3.54
Price/book (mrq)2.20
Enterprise value/revenue 4.05
Enterprise value/EBITDA 14.70

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 3-4.00%
S&P500 52-week change 326.49%
52-week high 391.00
52-week low 368.84
50-day moving average 382.87
200-day moving average 381.15

Share statistics

Avg vol (3-month) 36.02M
Avg vol (10-day) 35.15M
Shares outstanding 51.33B
Implied shares outstanding 61.33B
Float 81.33B
% held by insiders 10.11%
% held by institutions 185.73%
Shares short (30 Apr 2024) 414.03M
Short ratio (30 Apr 2024) 42.32
Short % of float (30 Apr 2024) 41.06%
Short % of shares outstanding (30 Apr 2024) 41.06%
Shares short (prior month 28 Mar 2024) 412.43M

Dividends & splits

Forward annual dividend rate 42.76
Forward annual dividend yield 43.21%
Trailing annual dividend rate 32.75
Trailing annual dividend yield 33.21%
5-year average dividend yield 42.52
Payout ratio 487.30%
Dividend date 312 Apr 2024
Ex-dividend date 421 Mar 2024
Last split factor 22:1
Last split date 327 Sept 1999

Financial highlights

Fiscal year

Fiscal year ends 28 Apr 2023
Most-recent quarter (mrq)26 Jan 2024


Profit margin 13.00%
Operating margin (ttm)19.17%

Management effectiveness

Return on assets (ttm)4.23%
Return on equity (ttm)8.17%

Income statement

Revenue (ttm)32.32B
Revenue per share (ttm)24.30
Quarterly revenue growth (yoy)4.70%
Gross profit (ttm)N/A
Net income avi to common (ttm)4.2B
Diluted EPS (ttm)3.15
Quarterly earnings growth (yoy)8.20%

Balance sheet

Total cash (mrq)8.32B
Total cash per share (mrq)6.27
Total debt (mrq)25.18B
Total debt/equity (mrq)48.43%
Current ratio (mrq)2.30
Book value per share (mrq)38.95

Cash flow statement

Operating cash flow (ttm)6.47B
Levered free cash flow (ttm)5.51B